CLDX
Celldex Therapeutics Inc
31.10$
-1.2%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +66.1% | +86.6% | -2.7% | -2.6% | -3.7% | -6.7% | -6.4% | -6.4% | -10.1% | -12.3% | +53.0% | |
| – | +75.5% | +93.5% | -2.8% | -4.1% | -4.1% | -7.1% | -6.5% | -6.8% | -11.5% | -14.1% | +57.9% | |
| – | +64.7% | +230.5% | -62.9% | -14.8% | -22.1% | -39.6% | +34.5% | +56.4% | -19.9% | +23.8% | +32.8% | |
| – | +79.2% | +95.4% | -2.6% | -5.8% | -4.1% | -7.2% | -6.4% | -7.5% | -11.1% | -12.9% | +58.9% | |
| – | +1,696.8% | -41.0% | -42.6% | -44.5% | -17.8% | +52.0% | -91.5% | +0.0% | +2,138.9% | -88.6% | +0.0% | |
| – | +0.0% | +0.0% | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | +8.7% | -17.1% | +5.6% | +16.7% | +21.6% | -19.5% | +1.4% | +35.3% | +11.5% | -1.4% | +23.2% | |
| – | +11.8% | -15.5% | +5.2% | +16.0% | +23.1% | -18.9% | +3.0% | +41.0% | +9.7% | +0.9% | +19.1% | |
| – | +4.3% | +1.9% | -3.3% | -13.2% | +5.3% | +3.2% | +2.5% | +1.1% | -0.1% | -5.6% | +6.3% | |
| – | -2.6% | -7.4% | +17.6% | -70.7% | +193.1% | +4.4% | -39.2% | +105.8% | -72.3% | +777.9% | +41.7% | |
| – | +74.0% | +95.4% | -3.0% | -3.4% | -4.9% | -5.9% | -6.8% | -8.7% | -11.9% | -13.5% | +56.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +10.1% | +13.2% | +12.1% | +0.4% | +0.1% | +0.0% | +0.0% | +0.0% | +0.1% | +0.1% | +16.9% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.